0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endocrine And Metabolic Disorders Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Gout Medications Market - Global Forecast 2025-2030 - Product Thumbnail Image

Gout Medications Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Denosumab Injection Market - Global Forecast 2025-2030 - Product Thumbnail Image

Denosumab Injection Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 193 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Insulin Analog Market - Global Forecast to 2030 - Product Thumbnail Image

Insulin Analog Market - Global Forecast to 2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Vildagliptin API Market - Global Forecast to 2030 - Product Thumbnail Image

Vildagliptin API Market - Global Forecast to 2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Long-Acting Insulin Analogue Market - Global Forecast to 2030 - Product Thumbnail Image

Long-Acting Insulin Analogue Market - Global Forecast to 2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Hypoprothrombinemia Treatment Market - Global Forecast to 2030 - Product Thumbnail Image

Hypoprothrombinemia Treatment Market - Global Forecast to 2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Amyloidosis Treatment Market - Global Forecast 2025-2030 - Product Thumbnail Image

Amyloidosis Treatment Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Carglumic Acid Market - Global Forecast 2025-2030 - Product Thumbnail Image

Carglumic Acid Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Synthetic Hormones Market - Global Forecast 2025-2030 - Product Thumbnail Image

Synthetic Hormones Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Human Insulin Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Human Insulin Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 184 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Type 2 Diabetes Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Type 2 Diabetes Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 184 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Human Growth Hormone Market - Global Forecast 2025-2030 - Product Thumbnail Image

Human Growth Hormone Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Loading Indicator

The Endocrine and Metabolic Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat endocrine and metabolic disorders. Endocrine disorders are conditions that affect the body's hormones, while metabolic disorders are conditions that affect the body's ability to process and use energy. Endocrine and metabolic disorders can include diabetes, thyroid disorders, obesity, and adrenal disorders. Endocrine and Metabolic Disorders Drugs are typically developed by pharmaceutical companies and are prescribed by physicians. These drugs can be used to treat a variety of endocrine and metabolic disorders, including diabetes, thyroid disorders, obesity, and adrenal disorders. Common drugs used to treat these conditions include insulin, metformin, and glucagon-like peptide-1 (GLP-1) agonists. Some of the major companies in the Endocrine and Metabolic Disorders Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the development, production, and marketing of drugs used to treat endocrine and metabolic disorders. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more